Your session is about to expire
← Back to Search
Ozanimod for Ulcerative Colitis
Study Summary
This trial is studying how well a medication works in people with ulcerative colitis in real-world settings.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2017 Phase 3 trial • 1320 Patients • NCT02047734Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- My ulcerative colitis is moderate to severe, based on a specific score.I have abnormal colon cells that haven't been removed.I have had severe colon issues or a bowel tear in the last 3 months.I have been diagnosed with ulcerative colitis for at least 3 months.I have had a major surgery to remove part of my colon or I currently have a stoma.
- Group 1: Cohort 1 - Advanced therapy-naive
- Group 2: Cohort 2 - Advanced therapy-exposed
- Drug Has Already Been Approved - The FDA has already approved this drug, and is just seeking more data.
- All Individual Drugs Already Approved - Therapies where all constituent drugs have already been approved are likely to have better-understood side effect profiles.
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
How many medical institutions are implementing this research experiment?
"This research endeavour is inviting participants from Gastroenterology Associates of Florida (GI Allianc in Wellington, FL), Gastroenterology Consultants, PC in Roswell, GA , Rocky Mountain Gastroenterology (RMG) - Littleton in Littleton, CO and 61 other locations."
What is the overall aim of this experiment?
"This medical research, which will span a maximum of 26 weeks, is intended to evaluate clinical response through the modified Mayo score. Secondary objectives include determining adverse events in Cohort 1 and 2 patients, histo-endoscopic mucosal improvement exclusively among cohort two individuals, as well as endoscopic responses across both cohorts."
Are there any remaining slots in this research endeavor for potential participants?
"According to the clinicaltrials.gov portal, this medical trial is not at present recruiting patients; its initial posting was on November 18th 2022 and it lastly updated on 23rd of that same month. Nevertheless, there are 399 other trials actively searching for volunteers right now."
Is Ozanimod likely to pose any risks or harm when taken by people?
"Ozanimod's safety is deemed reliable and worthy of a score of 3, as it has been approved for human use by the Food and Drug Administration."
Who else is applying?
What state do they live in?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
What questions have other patients asked about this trial?
Share this study with friends
Copy Link
Messenger